Ashwin S Nathan
Overview
Explore the profile of Ashwin S Nathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah T, Zhang Z, Shah H, Fanaroff A, Nathan A, Parise H, et al.
JACC Cardiovasc Interv
. 2025 Feb;
PMID: 39985508
Background: Aortic stenosis (AS) is the leading cause of valvular heart disease-related morbidity and mortality, but there are no medical treatments to slow its progression. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have...
2.
Nathan A, Kennedy K, Reddy K, Fanaroff A, Kolansky D, Kobayashi T, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e038317.
PMID: 39968808
Background: There may be variability in willingness to perform percutaneous coronary intervention (PCI) in higher-risk patients who present with ST-segment-elevation myocardial infarction (STEMI). We sought to describe current treatment selection...
3.
Reddy K, Mehta S, Eberly L, Khatana S, Wang G, Damrauer S, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39800119
Objective: Peripheral artery disease (PAD) affects >12 million Americans and poses significant financial burdens on patients, but the relationship between delayed/forgone (D/F) care and resource use in this population is...
4.
Ramadan O, Yang L, Shultz K, Genovese E, Damrauer S, Wang G, et al.
Circ Cardiovasc Qual Outcomes
. 2025 Jan;
18(1):e010931.
PMID: 39749477
Background: Black patients, those with low socioeconomic status (SES), and those living in rural areas have elevated rates of major lower extremity amputation, which may be related to a lack...
5.
Reddy K, Shutlz K, Eberly L, Khatana S, Fanaroff A, David G, et al.
Am Heart J
. 2024 Dec;
281:43-48.
PMID: 39631452
Introduction: We sought to measure the revenues, costs, and contribution margins (CMs) for major inpatient cardiovascular procedures in the Medicare population in years 2016-2019, evaluate the differences in CMs across...
6.
Reddy K, Shultz K, Eberly L, Khatana S, Fanaroff A, Kumbhani D, et al.
Am Heart J
. 2024 Nov;
281:59-70.
PMID: 39613171
Background: Hospitals and health systems must balance the demand for transcatheter aortic valve replacement (TAVR) against financial sustainability. Patients may be eligible for both TAVR and surgical aortic valve replacement...
7.
Association of Homelessness and Unstable Housing With Cardiovascular Care Utilization Among Veterans
Sokoloff L, Wu J, Eberly L, Nathan A, Julien H, Kobayashi T, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e010993.
PMID: 39492715
Background: Veterans are disproportionately more likely to experience homelessness and unstable housing (HUH) compared with the general population. Cardiovascular disease is the leading cause of death among Veterans experiencing HUH....
8.
Maurizi N, Antiochos P, Owens A, Lakdwala N, Saberi S, Russell M, et al.
Circulation
. 2024 Oct;
150(17):1377-1390.
PMID: 39355918
Background: Septal reduction therapy (SRT) provides substantial symptomatic improvement in patients with obstructive hypertrophic cardiomyopathy (HCM). However, long-term disease course after SRT and predictors of adverse outcomes have not been...
9.
Khatana S, Szeto J, Eberly L, Nathan A, Puvvula J, Chen A
JAMA Netw Open
. 2024 Sep;
7(9):e2434942.
PMID: 39302674
Importance: Extreme heat in the US is increasing due to climate change, while extreme cold is projected to decline. Understanding how extreme temperature along with demographic changes will affect population...
10.
Tran A, Toma C, Jaber W, Heintz J, Matthai W, Palevsky H, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(2):101187.
PMID: 39132209
Background: Catheter-directed thrombolysis (CDT) and large-bore mechanical thrombectomy (MT) are the leading percutaneous-based therapies for the management of intermediate-risk pulmonary embolism (PE). While previous studies have demonstrated their procedural safety...